Skip to content

Investigator

Sonya Eremenco

CRITICAL PATH INSTITUTE · funded by FDA

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$500k

Summed across those awards.

First award
Sep 1, 2024

Latest Sep 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. U01

    Psychometric Analyses and Quantitative Study Report for Qualification of the Pediatric Asthma Diary-Child (PAD-C) and the Pediatric Asthma Diary-Observer (PAD-O) (DDT COA #000099)

    $250k

    Sep 1, 2025FDACRITICAL PATH INSTITUTENIH RePORTER · 11328755 (opens the source filing in a new tab)

  2. U01

    Development of a Qualification Plan for the Virtual Reality Functional Capacity Assessment Tool - Short List (VRFCAT-SLx) (DDT COA #000004)

    $250k

    Sep 1, 2024FDACRITICAL PATH INSTITUTENIH RePORTER · 11181561 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources